Measuring Physical Activity in Juvenile Idiopathic Arthritis: Activity Diary Versus Accelerometer
Overview
Authors
Affiliations
Objective: (1) To determine convergent validity of an activity diary (AD) and accelerometer (Actical brand/Phillips-Respironics) in measuring physical activity (PA) in children with juvenile idiopathic arthritis (JIA). (2) To determine how many days give reliable results. (3) To analyze effects of correcting accelerometer data for non-wear.
Methods: Patients with JIA (8-13 yrs) were recruited from 3 Dutch pediatric rheumatology centers. PA was assessed for 7 days with an AD and accelerometer, and was expressed as mean min/day of rest, light PA (LPA), moderate to vigorous PA (MVPA), and PA level (PAL). To analyze convergent validity, intraclass correlation coefficients (ICC) were calculated and paired sample Student t tests were performed. The required number of days to achieve reliable results was calculated using the Spearman-Brown prophecy formula.
Results: Convergent validity between AD and accelerometer was moderate for rest and PAL (ICC 0.41). ICC for LPA and MVPA were < 0.24. AD overestimated PAL and MVPA compared with the accelerometer. Wearing the accelerometer 7-19 days gave reliable PA estimates on group and individual levels. For the AD, 13-36 days were needed. Adjusting accelerometer data for non-wear resulted in a clinically relevant higher mean number of min/day spent in LPA (effect size 1.12), but not in MVPA (effect size 0.44).
Conclusion: Convergent validity between AD and accelerometer is moderate to poor. In children with JIA, 1-week assessment with an accelerometer is sufficient to measure PA (all levels) reliably. On an individual level and for clinical use, 3 weeks are required. Additional use of AD enables correction for non-wear of accelerometer data.
Suc A, Einfalt L, Sarabon N, Kastelic K Int J Behav Nutr Phys Act. 2024; 21(1):83.
PMID: 39095778 PMC: 11295502. DOI: 10.1186/s12966-024-01632-4.
Ozdemir B, Savci S, Tanriverdi A, Ozcan Kahraman B, Isguder R, Makay B Z Rheumatol. 2023; 83(Suppl 1):71-77.
PMID: 37010629 DOI: 10.1007/s00393-023-01340-7.
Butler S, Sculley D, Santos D, Fellas A, Girones X, Singh-Grewal D J Med Internet Res. 2022; 24(2):e30457.
PMID: 35107431 PMC: 8851322. DOI: 10.2196/30457.
Fit-for-Purpose Biometric Monitoring Technologies: Leveraging the Laboratory Biomarker Experience.
Godfrey A, Vandendriessche B, Bakker J, Fitzer-Attas C, Gujar N, Hobbs M Clin Transl Sci. 2020; 14(1):62-74.
PMID: 32770726 PMC: 7877826. DOI: 10.1111/cts.12865.
Floden A, Brostrom E, von Heideken J, Rostlund S, Nilsson R, Lowing K Pediatr Rheumatol Online J. 2019; 17(1):16.
PMID: 31023371 PMC: 6482510. DOI: 10.1186/s12969-019-0317-6.